MENU
BIOY
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

BIOY stock forecast, quote, news & analysis

The investment seeks is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index (the “underlying index”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the underlying index (the “Underlying Leveraged ETF”)... Show more

Category: #Trading
BIOY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BIOY with price predictions
Sep 29, 2026

BIOY's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for BIOY moved out of overbought territory on September 09, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 instances where the indicator moved out of the overbought zone. In 1 of the 1 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2026. You may want to consider a long position or call options on BIOY as a result. In 4 of 4 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for BIOY just turned positive on September 28, 2026. Looking at past instances where BIOY's MACD turned positive, the stock continued to rise in 1 of 1 cases over the following month. The odds of a continued upward trend are 90%.

BIOY moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOY advanced for three days, in 23 of 30 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

BIOY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 6 of 6 cases where BIOY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

A.I.Advisor
published Highlights

Industry description

The investment seeks is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index (the “underlying index”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the underlying index (the “Underlying Leveraged ETF”). It is an actively managed exchange-traded fund (“ETF”) that seeks to pay weekly distributions by selling put options on the Underlying Leveraged ETF, which provides exposure to 3 times the daily performance of the underlying index. The fund is non-diversified.
View a ticker or compare two or three
BIOY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Derivative Income
Address
GraniteShares ETF Trust30 Vesey Street, 9th FloorNew York
Phone
N/A
Web
N/A